GABAPENTIN
- Product NDC
- 58657-621
- 11-digit product format
- 586570621
- Labeler code
- 58657
- Product ID
- 58657-621_aedea5a7-821d-4ddd-a977-c4c576cdfb04
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Method Pharmaceuticals, LLC
- Application
- ANDA204989
- Marketing category
- ANDA
- Marketing start
- 2016-09-30
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58657-621-01 | 58657062101 | 100 CAPSULE in 1 BOTTLE (58657-621-01) | 100 capsule | 2016-09-30 | 0000-00-00 | No | No | Current |
| 58657-621-50 | 58657062150 | 500 CAPSULE in 1 BOTTLE (58657-621-50) | 500 capsule | 2016-09-30 | 0000-00-00 | No | No | Current |